Treatment patterns for prostate cancer: Comparison of medicare claims data to medical record review

Steven T. Fleming, Ann S. Hamilton, Susan A. Sabatino, Gretchen G. Kimmick, Xiao Cheng Wu, Jean B. Owen, Bin Huang, Wenke Hwang

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Background: As evidence-based guidelines increasingly define standards of care, the accurate reporting of patterns of treatment becomes critical to determine if appropriate care has been provided. We explore the level of agreement between claims and record abstraction for treatment regimens for prostate cancer. Methods: Medicare claims data were linked to medical records abstraction using data from the Centers for Disease Control and Prevention's National Program of Cancer Registry-funded Breast and Prostate Patterns of Care study. The first course of therapy included surgery, radiation therapy (RT), and hormonal therapy with luteinizing hormone-releasing hormone agonists. Results: The linked sample included 2765 men most (84.7%) of whom had stage II prostate cancer. Agreement was excellent for surgery (κ=0.92) and RT (κ=0.92) and lower for hormonal therapy (κ=0.71); however, most of the discrepancies were due to greater number of patients reported who received hormonal therapy in the claims database than in the medical records database. For some standard multicomponent management strategies sensitivities were high, for example, hormonal therapy with either combination RT (86.9%) or cryosurgery (96.6%). Conclusions: Medicare claims are sensitive for determining patterns of multicomponent care for prostate cancer and for detecting use of hormonal therapy when not reported in the medical records abstracts.

Original languageEnglish (US)
JournalMedical care
Volume52
Issue number9
DOIs
StatePublished - Jan 1 2014

Fingerprint

Medicare
Medical Records
Prostatic Neoplasms
Radiotherapy
Therapeutics
Databases
Cryosurgery
Standard of Care
Centers for Disease Control and Prevention (U.S.)
Gonadotropin-Releasing Hormone
Registries
Prostate
Breast
Guidelines
Neoplasms

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health

Cite this

Fleming, Steven T. ; Hamilton, Ann S. ; Sabatino, Susan A. ; Kimmick, Gretchen G. ; Wu, Xiao Cheng ; Owen, Jean B. ; Huang, Bin ; Hwang, Wenke. / Treatment patterns for prostate cancer : Comparison of medicare claims data to medical record review. In: Medical care. 2014 ; Vol. 52, No. 9.
@article{8e2dce38c6b14123ab599c371420e9ab,
title = "Treatment patterns for prostate cancer: Comparison of medicare claims data to medical record review",
abstract = "Background: As evidence-based guidelines increasingly define standards of care, the accurate reporting of patterns of treatment becomes critical to determine if appropriate care has been provided. We explore the level of agreement between claims and record abstraction for treatment regimens for prostate cancer. Methods: Medicare claims data were linked to medical records abstraction using data from the Centers for Disease Control and Prevention's National Program of Cancer Registry-funded Breast and Prostate Patterns of Care study. The first course of therapy included surgery, radiation therapy (RT), and hormonal therapy with luteinizing hormone-releasing hormone agonists. Results: The linked sample included 2765 men most (84.7{\%}) of whom had stage II prostate cancer. Agreement was excellent for surgery (κ=0.92) and RT (κ=0.92) and lower for hormonal therapy (κ=0.71); however, most of the discrepancies were due to greater number of patients reported who received hormonal therapy in the claims database than in the medical records database. For some standard multicomponent management strategies sensitivities were high, for example, hormonal therapy with either combination RT (86.9{\%}) or cryosurgery (96.6{\%}). Conclusions: Medicare claims are sensitive for determining patterns of multicomponent care for prostate cancer and for detecting use of hormonal therapy when not reported in the medical records abstracts.",
author = "Fleming, {Steven T.} and Hamilton, {Ann S.} and Sabatino, {Susan A.} and Kimmick, {Gretchen G.} and Wu, {Xiao Cheng} and Owen, {Jean B.} and Bin Huang and Wenke Hwang",
year = "2014",
month = "1",
day = "1",
doi = "10.1097/MLR.0b013e318277eba5",
language = "English (US)",
volume = "52",
journal = "Medical Care",
issn = "0025-7079",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

Treatment patterns for prostate cancer : Comparison of medicare claims data to medical record review. / Fleming, Steven T.; Hamilton, Ann S.; Sabatino, Susan A.; Kimmick, Gretchen G.; Wu, Xiao Cheng; Owen, Jean B.; Huang, Bin; Hwang, Wenke.

In: Medical care, Vol. 52, No. 9, 01.01.2014.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Treatment patterns for prostate cancer

T2 - Comparison of medicare claims data to medical record review

AU - Fleming, Steven T.

AU - Hamilton, Ann S.

AU - Sabatino, Susan A.

AU - Kimmick, Gretchen G.

AU - Wu, Xiao Cheng

AU - Owen, Jean B.

AU - Huang, Bin

AU - Hwang, Wenke

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background: As evidence-based guidelines increasingly define standards of care, the accurate reporting of patterns of treatment becomes critical to determine if appropriate care has been provided. We explore the level of agreement between claims and record abstraction for treatment regimens for prostate cancer. Methods: Medicare claims data were linked to medical records abstraction using data from the Centers for Disease Control and Prevention's National Program of Cancer Registry-funded Breast and Prostate Patterns of Care study. The first course of therapy included surgery, radiation therapy (RT), and hormonal therapy with luteinizing hormone-releasing hormone agonists. Results: The linked sample included 2765 men most (84.7%) of whom had stage II prostate cancer. Agreement was excellent for surgery (κ=0.92) and RT (κ=0.92) and lower for hormonal therapy (κ=0.71); however, most of the discrepancies were due to greater number of patients reported who received hormonal therapy in the claims database than in the medical records database. For some standard multicomponent management strategies sensitivities were high, for example, hormonal therapy with either combination RT (86.9%) or cryosurgery (96.6%). Conclusions: Medicare claims are sensitive for determining patterns of multicomponent care for prostate cancer and for detecting use of hormonal therapy when not reported in the medical records abstracts.

AB - Background: As evidence-based guidelines increasingly define standards of care, the accurate reporting of patterns of treatment becomes critical to determine if appropriate care has been provided. We explore the level of agreement between claims and record abstraction for treatment regimens for prostate cancer. Methods: Medicare claims data were linked to medical records abstraction using data from the Centers for Disease Control and Prevention's National Program of Cancer Registry-funded Breast and Prostate Patterns of Care study. The first course of therapy included surgery, radiation therapy (RT), and hormonal therapy with luteinizing hormone-releasing hormone agonists. Results: The linked sample included 2765 men most (84.7%) of whom had stage II prostate cancer. Agreement was excellent for surgery (κ=0.92) and RT (κ=0.92) and lower for hormonal therapy (κ=0.71); however, most of the discrepancies were due to greater number of patients reported who received hormonal therapy in the claims database than in the medical records database. For some standard multicomponent management strategies sensitivities were high, for example, hormonal therapy with either combination RT (86.9%) or cryosurgery (96.6%). Conclusions: Medicare claims are sensitive for determining patterns of multicomponent care for prostate cancer and for detecting use of hormonal therapy when not reported in the medical records abstracts.

UR - http://www.scopus.com/inward/record.url?scp=84906086767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906086767&partnerID=8YFLogxK

U2 - 10.1097/MLR.0b013e318277eba5

DO - 10.1097/MLR.0b013e318277eba5

M3 - Review article

C2 - 23222532

AN - SCOPUS:84906086767

VL - 52

JO - Medical Care

JF - Medical Care

SN - 0025-7079

IS - 9

ER -